Phenotyping the effect of diet on non-alcoholic fatty liver disease

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1370-1373

  De Wit, Nicole J W ^a   Afman, Lydia A ^a   Mensink, Marco ^a   Müller, Michael ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Genomics techniques; Macronutrients; Micronutrients; NAFLD; NASH

Indexed keywords

ANTIOXIDANT; CARBOHYDRATE; CHOLINE; FRUCTOSE; ISOFLAVONE; SATURATED FATTY ACID; UNSATURATED FATTY ACID;

ADIPOSE TISSUE; ARTICLE; DIET; DISEASE COURSE; HUMAN; INTESTINE; LIPID OXIDATION; LIPID STORAGE; LIVER; MACRONUTRIENT; METABOLOMICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DIET; PROTEOMICS; TRANSCRIPTOMICS;

EID: 84869213871     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.003     Document Type: Note

References (25)

1. K. Toshimitsu, B. Matsuura, I. Ohkubo, T. Niiya, S. Furukawa, and Y. Hiasa Dietary habits and nutrient intake in non-alcoholic steatohepatitis Nutrition 23 2007 46 52
2. G. Musso, R. Gambino, G. Pacini, F. De Michieli, and M. Cassader Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver Am J Clin Nutr 89 2009 558 567
3. M.V. Machado, P. Ravasco, L. Jesus, P. Marques-Vidal, C.R. Oliveira, and T. Proenca Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet Scand J Gastroenterol 43 2008 95 102
4. N. Assy, F. Nassar, G. Nasser, and M. Grosovski Olive oil consumption and non-alcoholic fatty liver disease World J Gastroenterol 15 2009 1809 1815
5. G.S. Masterton, J.N. Plevris, and P.C. Hayes Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease Aliment Pharmacol Ther 31 2010 679 692
6. M. Maersk, A. Belza, H. Stodkilde-Jorgensen, S. Ringgaard, E. Chabanova, and H. Thomsen Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study Am J Clin Nutr 95 2012 283 289
7. K.L. Stanhope, J.M. Schwarz, N.L. Keim, S.C. Griffen, A.A. Bremer, and J.L. Graham Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans J Clin Invest 119 2009 1322 1334
8. H. Basciano, L. Federico, and K. Adeli Fructose, insulin resistance, and metabolic dyslipidemia Nutr Metab 2 2005 5
9. K. Nomura, and T. Yamanouchi The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease J Nutr Biochem 23 2012 203 208
10. M. Bortolotti, E. Maiolo, M. Corazza, E. Van Dijke, P. Schneiter, and A. Boss Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients Clin Nutr 30 2011 494 498
11. H.Y. Yang, Y.H. Tzeng, C.Y. Chai, A.T. Hsieh, J.R. Chen, and L.S. Chang Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis Nutrition 27 2011 943 948
12. C.L. Gentile, A.M. Nivala, J.C. Gonzales, K.T. Pfaffenbach, D. Wang, and Y. Wei Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease Am J Physiol Regul Integr Comp Physiol 301 2011 R1710 R1722
13. T. Hashidume, T. Sasaki, J. Inoue, and R. Sato Consumption of soy protein isolate reduces hepatic SREBP-1c and lipogenic gene expression in wild-type mice, but not in FXR-deficient mice Biosci Biotechnol Biochem 75 2011 1702 1707
14. K.D. Corbin, and S.H. Zeisel Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression Curr Opin Gastroenterol 28 2012 159 165
15. J.M. Smoliga, J.A. Baur, and H.A. Hausenblas Resveratrol and health - A comprehensive review of human clinical trials Mol Nutr Food Res 55 2011 1129 1141
16. Kim MH, Kang KS. Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling. Prev Med 2012;54(Suppl.):S57-S63.
17. L.A. Afman, and M. Muller Human nutrigenomics of gene regulation by dietary fatty acids Prog Lipid Res 51 2012 63 70
18. J.T. Stefano, C.P.M.S. de Oliveira, M.L. Corrêa-Giannella, I.C. Soares, M.S. Kubrusly, and M. Bellodi-Privato Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? Liver Int 31 2011 377 385
19. C. Duval, U. Thissen, S. Keshtkar, B. Accart, R. Stienstra, and M.V. Boekschoten Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57Bl/6 mice Diabetes 59 2010 3181 3191
20. L.N. Bell, J.L. Theodorakis, R. Vuppalanchi, R. Saxena, K.G. Bemis, and M. Wang Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease Hepatology 51 2010 111 120
21. J.-E. Park, H.T. Kim, S. Lee, Y.-S. Lee, U.-K. Choi, and J.H. Kang Differential expression of intermediate filaments in the process of developing hepatic steatosis Proteomics 11 2011 2777 2789
22. J. Shen, H.L.-Y. Chan, G.L.-H. Wong, P.C.-L. Choi, A.W.-H. Chan, and H.-Y. Chan Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers J Hepatol 56 2012 1363 1370
23. S.C. Kalhan, L. Guo, J. Edmison, S. Dasarathy, A.J. McCullough, and R.W. Hanson Plasma metabolomic profile in nonalcoholic fatty liver disease Metabolism 60 2011 404 413
24. H. Li, L. Wang, X. Yan, Q. Liu, C. Yu, and H. Wei A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease J Proteome Res 10 2011 2797 2806
25. I. Rubio-Aliaga, B. Roos, M. Sailer, G.A. McLoughlin, M.V. Boekschoten, and M. van Erk Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention Physiol Genomics 43 2011 408 416